• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病心肌病发病机制的难题:血管内皮功能障碍、活性氧和线粒体的作用。

Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria.

机构信息

Department of Surgery, University of Connecticut Health Center, Farmington Avenue, Farmington, CT, 06032, USA.

出版信息

Mol Cell Biochem. 2014 Jan;386(1-2):233-49. doi: 10.1007/s11010-013-1861-x. Epub 2013 Dec 4.

DOI:10.1007/s11010-013-1861-x
PMID:24307101
Abstract

Diabetic cardiomyopathy and heart failure have been recognized as the leading causes of mortality among diabetics. Diabetic cardiomyopathy has been characterized primarily by the manifestation of left ventricular dysfunction that is independent of coronary artery disease and hypertension among the patients affected by diabetes mellitus. A complex array of contributing factors including the hypertrophy of left ventricle, alterations of metabolism, microvascular pathology, insulin resistance, fibrosis, apoptotic cell death, and oxidative stress have been implicated in the pathogenesis of diabetic cardiomyopathy. Nevertheless, the exact mechanisms underlying the pathogenesis of diabetic cardiomyopathy are yet to be established. The critical involvement of multifarious factors including the vascular endothelial dysfunction, microangiopathy, reactive oxygen species (ROS), oxidative stress, mitochondrial dysfunction has been identified in the mechanism of pathogenesis of diabetic cardiomyopathy. Although it is difficult to establish how each factor contributes to disease, the involvement of ROS and mitochondrial dysfunction are emerging as front-runners in the mechanism of pathogenesis of diabetic cardiomyopathy. This review highlights the role of vascular endothelial dysfunction, ROS, oxidative stress, and mitochondriopathy in the pathogenesis of diabetic cardiomyopathy. Furthermore, the review emphasizes that the puzzle has to be solved to firmly establish the mitochondrial and/or ROS mechanism(s) by identifying their most critical molecular players involved at both spatial and temporal levels in diabetic cardiomyopathy as targets for specific and effective pharmacological/therapeutic interventions.

摘要

糖尿病性心肌病和心力衰竭已被认为是糖尿病患者死亡的主要原因。糖尿病性心肌病的主要特征是左心室功能障碍,这与糖尿病患者的冠状动脉疾病和高血压无关。一系列复杂的致病因素,包括左心室肥大、代谢改变、微血管病变、胰岛素抵抗、纤维化、细胞凋亡和氧化应激,都与糖尿病性心肌病的发病机制有关。然而,糖尿病性心肌病发病机制的确切机制尚未确定。血管内皮功能障碍、微血管病变、活性氧(ROS)、氧化应激、线粒体功能障碍等多种因素的关键参与,已被确定为糖尿病性心肌病发病机制中的重要因素。尽管很难确定每个因素对疾病的贡献程度,但 ROS 和线粒体功能障碍的参与正成为糖尿病性心肌病发病机制中的领跑者。本文综述了血管内皮功能障碍、ROS、氧化应激和线粒体病变在糖尿病性心肌病发病机制中的作用。此外,本文强调,必须通过确定糖尿病性心肌病中空间和时间水平上最关键的分子靶点,解决这个难题,以确定线粒体和/或 ROS 机制作为特定和有效的药物干预的靶点。

相似文献

1
Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria.糖尿病心肌病发病机制的难题:血管内皮功能障碍、活性氧和线粒体的作用。
Mol Cell Biochem. 2014 Jan;386(1-2):233-49. doi: 10.1007/s11010-013-1861-x. Epub 2013 Dec 4.
2
Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options.我们能否预防 1 型糖尿病中的线粒体功能障碍和糖尿病心肌病?病理生理学和治疗选择。
Int J Mol Sci. 2020 Apr 19;21(8):2852. doi: 10.3390/ijms21082852.
3
Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits.阿格列汀可预防糖尿病兔舒张功能障碍并维持左心室线粒体功能。
Cardiovasc Diabetol. 2018 Dec 27;17(1):160. doi: 10.1186/s12933-018-0803-z.
4
p53 promotes cardiac dysfunction in diabetic mellitus caused by excessive mitochondrial respiration-mediated reactive oxygen species generation and lipid accumulation.p53 促进了由过度线粒体呼吸引起的活性氧产生和脂质积累导致的糖尿病性心脏功能障碍。
Circ Heart Fail. 2012 Jan;5(1):106-15. doi: 10.1161/CIRCHEARTFAILURE.111.961565. Epub 2011 Nov 9.
5
Mitochondrial dysfunction in diabetic cardiomyopathy.糖尿病性心肌病中的线粒体功能障碍
Biochim Biophys Acta. 2011 Jul;1813(7):1351-9. doi: 10.1016/j.bbamcr.2011.01.014. Epub 2011 Jan 20.
6
Endothelial Dysfunction and Diabetic Cardiomyopathy.内皮功能障碍与糖尿病心肌病。
Front Endocrinol (Lausanne). 2022 Apr 7;13:851941. doi: 10.3389/fendo.2022.851941. eCollection 2022.
7
Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy.糖尿病心肌病中与氧化应激相关的信号通路。
Front Endocrinol (Lausanne). 2022 Jun 15;13:907757. doi: 10.3389/fendo.2022.907757. eCollection 2022.
8
Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.血管内皮功能障碍,糖尿病心肌病的主要介质。
Acta Pharmacol Sin. 2019 Jan;40(1):1-8. doi: 10.1038/s41401-018-0042-6. Epub 2018 Jun 4.
9
Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy.用线粒体靶向抗氧化剂(mito-TEMPO)对线粒体活性氧进行治疗性抑制可减轻糖尿病性心肌病。
Free Radic Biol Med. 2016 Jan;90:12-23. doi: 10.1016/j.freeradbiomed.2015.11.013. Epub 2015 Nov 11.
10
Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart.糖尿病大鼠心脏中线粒体效率低下和缺氧 ATP 水解能力。
Am J Physiol Cell Physiol. 2014 Sep 15;307(6):C499-507. doi: 10.1152/ajpcell.00006.2014. Epub 2014 Jun 11.

引用本文的文献

1
A comprehensive review on diabetic cardiomyopathy (DCM): histological spectrum, diagnosis, pathogenesis, and management with conventional treatments and natural compounds.糖尿病性心肌病(DCM)的全面综述:组织学谱、诊断、发病机制以及传统治疗和天然化合物的管理
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 18. doi: 10.1007/s00210-025-03980-9.
2
Unveiling myocardial microstructure shifts: exploring the impact of diabetes in stable CAD patients through CMR T1 mapping.揭示心肌微观结构变化:通过心脏磁共振成像T1映射探索糖尿病对稳定型冠心病患者的影响。
Diabetol Metab Syndr. 2024 Jul 9;16(1):156. doi: 10.1186/s13098-024-01395-9.
3

本文引用的文献

1
Glutathione metabolism and Parkinson's disease.谷胱甘肽代谢与帕金森病。
Free Radic Biol Med. 2013 Sep;62:13-25. doi: 10.1016/j.freeradbiomed.2013.05.001. Epub 2013 May 8.
2
Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction.心肌梗死后的心脏氧化应激和炎性细胞因子反应。
Curr Vasc Pharmacol. 2015;13(1):26-36. doi: 10.2174/15701611113119990003.
3
Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases.天然外源性抗氧化剂对衰老和神经退行性疾病的影响。
Unraveling the Intricate Roles of Exosomes in Cardiovascular Diseases: A Comprehensive Review of Physiological Significance and Pathological Implications.
解析外泌体在心血管疾病中的复杂作用:生理意义与病理影响的全面综述。
Int J Mol Sci. 2023 Oct 27;24(21):15677. doi: 10.3390/ijms242115677.
4
Activating transcription factor 4 drives the progression of diabetic cardiac fibrosis.激活转录因子 4 驱动糖尿病性心脏纤维化的进展。
ESC Heart Fail. 2023 Aug;10(4):2510-2523. doi: 10.1002/ehf2.14404. Epub 2023 Jun 8.
5
Cellular and molecular mechanisms, genetic predisposition and treatment of diabetes-induced cardiomyopathy.糖尿病性心肌病的细胞与分子机制、遗传易感性及治疗
Curr Res Pharmacol Drug Discov. 2022 Sep 3;3:100126. doi: 10.1016/j.crphar.2022.100126. eCollection 2022.
6
Molecular Mechanisms of Hawthorn Extracts in Multiple Organs Disorders in Underlying of Diabetes: A Review.山楂提取物对糖尿病相关多器官疾病的分子作用机制:综述
Int J Endocrinol. 2022 Jun 7;2022:2002768. doi: 10.1155/2022/2002768. eCollection 2022.
7
[Fucoxanthin regulates Nrf2/Keap1 signaling to alleviate myocardial hypertrophy in diabetic rats].[岩藻黄质通过调节Nrf2/Keap1信号通路减轻糖尿病大鼠心肌肥厚]
Nan Fang Yi Ke Da Xue Xue Bao. 2022 May 20;42(5):752-759. doi: 10.12122/j.issn.1673-4254.2022.05.18.
8
Plin5, a New Target in Diabetic Cardiomyopathy.Plin5,糖尿病性心肌病的新靶点。
Oxid Med Cell Longev. 2022 Apr 25;2022:2122856. doi: 10.1155/2022/2122856. eCollection 2022.
9
Short-Term Effects of Supplemental L-Arginine, Diosmin, Troxerutin, and Hesperidin in Diabetic Patients: A Pilot Study.补充 L-精氨酸、地奥司明、曲克芦丁和橙皮苷对糖尿病患者的短期影响:一项初步研究。
Biomed Res Int. 2021 Dec 2;2021:3508281. doi: 10.1155/2021/3508281. eCollection 2021.
10
Emerging Role of Mitophagy in the Heart: Therapeutic Potentials to Modulate Mitophagy in Cardiac Diseases.线粒体自噬在心脏中的新兴作用:调节心脏疾病中线粒体自噬的治疗潜力。
Oxid Med Cell Longev. 2021 Sep 23;2021:3259963. doi: 10.1155/2021/3259963. eCollection 2021.
Free Radic Res. 2013 Jul;47(6-7):451-62. doi: 10.3109/10715762.2013.795649. Epub 2013 May 13.
4
Free radicals and antioxidants: how to reestablish redox homeostasis in chronic diseases?自由基和抗氧化剂:如何在慢性病中重新建立氧化还原平衡?
Curr Med Chem. 2013;20(27):3397-415. doi: 10.2174/0929867311320270005.
5
Emerging roles of cardiolipin remodeling in mitochondrial dysfunction associated with diabetes, obesity, and cardiovascular diseases.心磷脂重塑在与糖尿病、肥胖症和心血管疾病相关的线粒体功能障碍中的新作用。
J Biomed Res. 2010 Jan;24(1):6-15. doi: 10.1016/S1674-8301(10)60003-6.
6
Mitochondria and reactive oxygen species: physiology and pathophysiology.线粒体和活性氧:生理和病理生理学。
Int J Mol Sci. 2013 Mar 19;14(3):6306-44. doi: 10.3390/ijms14036306.
7
Structural changes in the myocardium during diabetes-induced cardiomyopathy.糖尿病性心肌病中心肌的结构变化。
Heart Fail Rev. 2014 Jan;19(1):15-23. doi: 10.1007/s10741-013-9388-5.
8
Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice.针对高血糖后活性氧的上调可预防小鼠 1 型糖尿病心肌病。
Free Radic Biol Med. 2013 Jul;60:307-17. doi: 10.1016/j.freeradbiomed.2013.02.021. Epub 2013 Feb 26.
9
Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.葡萄糖诱导的细胞信号在糖尿病心肌病发病机制中的作用。
Heart Fail Rev. 2014 Jan;19(1):75-86. doi: 10.1007/s10741-013-9381-z.
10
The elusive magic pill: finding effective therapies for mitochondrial disorders. elusive elusive adj. 难以捉摸的;不易找到的;难理解的;费解的
Neurotherapeutics. 2013 Apr;10(2):320-8. doi: 10.1007/s13311-012-0175-0.